<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">chemicallytech</journal-id><journal-title-group><journal-title xml:lang="en">Fine Chemical Technologies</journal-title><trans-title-group xml:lang="ru"><trans-title>Тонкие химические технологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-6593</issn><issn pub-type="epub">2686-7575</issn><publisher><publisher-name>MIREA – Russian Technological University (RTU MIREA).</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.32362/2410-6593-2022-17-6-492-503</article-id><article-id custom-type="elpub" pub-id-type="custom">chemicallytech-1910</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOCHEMISTRY AND BIOTECHNOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОХИМИЯ И БИОТЕХНОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Investigation of the biological activity of the water-soluble C60/poly-N-vinylpyrrolidone complex</article-title><trans-title-group xml:lang="ru"><trans-title>Исследование биологической активности водорастворимого комплекса C60/поли-N-винилпирролидон</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1618-6690</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логинова</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Loginova</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Логинова Наталия Юрьевна - кандидат химических наук, старший преподаватель кафедры биохимии.</p><p>410012, Приволжский федеральный округ, Саратовская область, г. Саратов, ул. Большая Казачья, д. 112</p></bio><bio xml:lang="en"><p>Natalia Yu. Loginova - Cand. Sci. (Chem.), Senior Lecturer, Department of Biochemistry.</p><p>112, Bolshaya Kazachya ul., Saratov, 410012, Volga Federal District, Saratov oblast</p></bio><email xlink:type="simple">loginova_nu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7732-0796</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чесовских</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Chesovskikh</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чесовских Юлия Сергеевна - кандидатбиологических наук, старший преподаватель кафедры биохимии, ResearcherID AAD-8570-2021, Scopus Author ID 56613371400</p><p>410012, Приволжский федеральный округ, Саратовская область, г. Саратов, ул. Большая Казачья, д. 112</p></bio><bio xml:lang="en"><p>Yulia S. Chesovskikh - Cand. Sci. (Biol.), Senior Lecturer, Department of Biochemistry, ResearcherID AAD-8570-2021, Scopus Author ID 56613371400.</p><p>112, Bolshaya Kazachya ul., Saratov, 410012, Volga Federal District, Saratov oblast</p></bio><email xlink:type="simple">Juliachesovskih@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1550-313X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бородулин</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Borodulin</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бородулин Владимир Борисович - доктор медицинских наук, профессор, заведующий кафедрой биохимии Саратовский ГМУ им. В.И. Разумовского; профессор кафедры аналитической химии им. И.П. Алимарина Института тонких химических технологий им. М.В. Ломоносова МИРЭА – РТУ, ResearcherID AAE-4632-2021, Scopus Author ID 57206159558.</p><p>410012, Приволжский федеральный округ, Саратовская область, Саратов, ул. Большая Казачья, д. 112; 119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Vladimir B. Borodulin - Dr. Sci. (Med.), Professor, Head of the Department of Biochemistry, V.I. Razumovsky Saratov SMU ; Professor, I.P. Alimarin Department of Analytical Chemistry, M.V. Lomonosov Institute of Fine Chemical Technologies, MIREA – RTU, ResearcherID AAE-4632-2021, Scopus Author ID 57206159558.</p><p>112, Bolshaya Kazachya ul., Saratov, 410012, Volga Federal District, Saratov oblast; 86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">borodulinvb@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Саратовский государственный медицинский университет им. В.И. Разумовского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Razumovsky Saratov State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Саратовский государственный медицинский университет им. В.И. Разумовского; МИРЭА – Российский технологический университет, Институт тонких химических технологий им. М.В. Ломоносова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Razumovsky Saratov State Medical University, Ministry of Health of the Russian Federation; MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>24</day><month>01</month><year>2023</year></pub-date><volume>17</volume><issue>6</issue><fpage>492</fpage><lpage>503</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Loginova N.Y., Chesovskikh Y.S., Borodulin V.B., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Логинова Н.Ю., Чесовских Ю.С., Бородулин В.Б.</copyright-holder><copyright-holder xml:lang="en">Loginova N.Y., Chesovskikh Y.S., Borodulin V.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.finechem-mirea.ru/jour/article/view/1910">https://www.finechem-mirea.ru/jour/article/view/1910</self-uri><abstract><sec><title>Objectives</title><p>Objectives. The study aimed to investigate the biological activity of the C60/poly-N-vinylpyrrolidone (C60/PVP) complex representing a water-soluble fullerene derivative. In vitro and in vivo techniques were used to analyze the effect of the C60/PVP complex on the activity of lactate dehydrogenase (LDH) and evaluate changes in the biochemical parameters of blood serum when per os administered to mice.</p></sec><sec><title>Methods</title><p>Methods. In order to determine the activity of a commercial LDH preparation and study the kinetics of this process, the standard Warburg photometric method was used. To assess the effect of polyvinylpyrrolidone (PVP) and the C60/PVP complex on some biochemical parameters in vivo, a study was conducted on two-month-old male white mongrel mice weighing 20 ± 3 g. Determination of biochemical parameters of blood serum was carried out using a semi-automatic biochemical analyzer according to standard methods.</p></sec><sec><title>Results</title><p>Results. The effect of the C60/PVP complex on LDH activity was studied along with changes in the biochemical parameters of mouse blood serum characterizing carbohydrate metabolism. As well as increasing the glucose and pyruvic acid content, the C60/PVP complex was found to reduce lactate content and LDH activity in blood serum along with in vitro LDH activity according to the type of mixed inhibition.</p></sec><sec><title>Conclusions</title><p>Conclusions. The C60/PVP complex and PVP were shown to exhibit biological activity in vitro and in vivo. The C60/PVP complex, representing a mixed-type LDH inhibitor, was shown to inhibit LDH activity, as well as contributing to a decrease in lactate concentration and an increase in the concentration of pyruvic acid and glucose in blood serum when administered per os to mice. The inhibitory effect of PVP on LDH activity was revealed in both in vivo and in vitro investigations. In vivo, PVP contributes to a decrease in the concentration of lactate in the blood. The less pronounced effect of the C60/PVP complex as compared to PVP alone may be due to the fact that C60 molecules are “hidden” in cavities formed in PVP molecules.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цели</title><p>Цели. Исследовать биологическую активность водорастворимого производного фуллерена – комплекса C60/поли-N-винилпирролидона (C60/ПВП) – в условиях in vitro и in vivo; изучить влияние комплекса C60/ПВП на активность лактатдегидрогеназы (ЛДГ) в условиях in vitro и in vivo; оценить изменения биохимических показателей сыворотки крови при введении мышам C60/ПВП per os.</p></sec><sec><title>Методы</title><p>Методы. Для определения активности коммерческого препарата ЛДГ и исследования кинетики данного процесса был использован фотометрический метод Варбурга с применением стандартной методики. Для оценки влияния поливинилпирролидона (ПВП) и комплекса C60/ПВП на некоторые биохимические показатели in vivo было проведено исследование на двухмесячных самцах белых беспородных мышей весом 20 ± 3 г. Определение биохимических показателей сыворотки крови проводилось с помощью полуавтоматического биохимического анализатора по стандартным методикам. Результаты. Исследовано влияние комплекса C60/ПВП на активность ЛДГ и проведена оценка изменений биохимических показателей сыворотки крови мышей, характеризующих углеводный обмен. Установлено, что комплекс C60/ПВП увеличивает содержание глюкозы и пировиноградной кислоты, снижает содержание лактата и активность ЛДГ в сыворотке крови по сравнению с контролем, а также снижает активность ЛДГ в условиях in vitro по типу смешанного ингибирования.</p></sec><sec><title>Выводы</title><p>Выводы. Комплексы C60/ПВП и ПВП проявляют биологическую активность в условиях in vitro и in vivo. Установлено, что комплекс C60/ПВП является ингибитором ЛДГ смешанного типа в условиях in vitro, угнетает активность ЛДГ в условиях in vivo, а также способствует снижению концентрации лактата и увеличению концентрации пировиноградной кислоты и глюкозы в сыворотке крови при введении мышам C60/ПВП per os. При этом также выявлено ингибирующее действие и ПВП на активность ЛДГ in vitro и in vitro, причем в условиях in vivo ПВП способствует снижению концентрации лактата в крови. Менее выраженное действие комплекса C60/ПВП по сравнению с ПВП может быть связано с тем, что молекулы C60 «скрыты» в полостях, образованных в молекулах ПВП.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фуллерен</kwd><kwd>C60</kwd><kwd>C60/поли-N-винилпирролидон</kwd><kwd>комплекс C60/ПВП</kwd><kwd>активность ЛДГ</kwd><kwd>биохимические показатели</kwd><kwd>биологическая активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fullerene</kwd><kwd>C60</kwd><kwd>C60/poly-N-vinylpyrrolidone</kwd><kwd>C60/PVP complex</kwd><kwd>LDH activity</kwd><kwd>biochemical parameters</kwd><kwd>biological activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen G., Roursgaard M., Jensen K., et al. In vivo Biology and Toxicology of Fullerenes and Their Derivatives. Basic Clin. Pharmacol. Toxicol. 2008;103(3):197–208. https://doi.org/10.1111/j.1742-7843.2008.00266.x</mixed-citation><mixed-citation xml:lang="en">Nielsen G., Roursgaard M., Jensen K., et al. In vivo Biology and Toxicology of Fullerenes and Their Derivatives. Basic Clin. Pharmacol. Toxicol. 2008;103(3):197–208. https://doi.org/10.1111/j.1742-7843.2008.00266.x</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shuster D.I., Wilson S.R., Shinazi R.F. Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes. Bioorg. Med. Chem. Lett. 1996;6(11):1253–1256. https://doi.org/10.1016/0960-894X(96)00210-7</mixed-citation><mixed-citation xml:lang="en">Shuster D.I., Wilson S.R., Shinazi R.F. Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes. Bioorg. Med. Chem. Lett. 1996;6(11):1253–1256. https://doi.org/10.1016/0960-894X(96)00210-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shinazi R.F., Sijbesma R., Sradanov G., et al. Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene Antimicrob. Agents Chemother.1993;37(8):1707–17110. https://doi.org/10.1128/AAC.37.8.1707</mixed-citation><mixed-citation xml:lang="en">Shinazi R.F., Sijbesma R., Sradanov G., et al. Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene Antimicrob. Agents Chemother.1993;37(8):1707–17110. https://doi.org/10.1128/AAC.37.8.1707</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bakry R., Vallant R., Najam-ul-Haq M., et al. Medicinal applications of fullerenes. Int. J. Nanomedicine. 2007;2(4):639–649.</mixed-citation><mixed-citation xml:lang="en">Bakry R., Vallant R., Najam-ul-Haq M., et al. Medicinal applications of fullerenes. Int. J. Nanomedicine. 2007;2(4):639–649.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ворошилов Е.А., Дегтярников В.П., Шуклина А.А. Перспективы применения мягких лекарственных форм с добавлением фуллерена C60 в терапии воспалительных процессов. В сб.: Медицинская помощь при травмах. Новое в организации и технологиях. Перспективы импортозамещения в России: Сборник тезисов Пятого юбилейного конгресса с международным участием. СПб.; 2020. С. 63–64.</mixed-citation><mixed-citation xml:lang="en">Voroshilov E.A., Degtyarnikov V.P., Shuklina A.A.Prospects for the use of soft dosage forms with the addition of fullerene C60 in the treatment of inflammatory processes. In: Meditsinskaya pomoshch’ pri travmakh. Novoe v organizatsii i tekhnologiyakh. Perspektivy importozameshcheniya v Rossii (Medical care for injuries. New in organization and technology. Prospects for import substitution in Russia): Collection of abstracts of the Fifth Anniversary Congress with International Participation. St. Petersburg; 2020. Р. 63–64 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992;59(5):1609–1623. https://doi.org/10.1111/j.1471-4159.1992.tb10990.x</mixed-citation><mixed-citation xml:lang="en">Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992;59(5):1609–1623. https://doi.org/10.1111/j.1471-4159.1992.tb10990.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Krustic P.J., Wasserman E., Keizer P.N., et al. Radical reactions of C60. Science. 1991;254(5035):1183–1185. https://doi.org/10.1126/science.254.5035.1183</mixed-citation><mixed-citation xml:lang="en">Krustic P.J., Wasserman E., Keizer P.N., et al. Radical reactions of C60. Science. 1991;254(5035):1183–1185. https://doi.org/10.1126/science.254.5035.1183</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Аверьянова М.О., Куракин Г.Ф., Лопина Н.П., Бордина Г.Е. Перспективы применения фуллеренов и их производных как антиоксидантов. Modern Science. 2019;(6–3):11–14.</mixed-citation><mixed-citation xml:lang="en">Aver’yanova M.O., Kurakin G.F., Lopina N.P., Bordina G.E. Prospects for the use of fullerenes and their derivatives as antioxidants. Modern Science. 2019;(6–3):11–14 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dugan L.L., et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001;7(3):243–246. https://doi.org/10.1016/S1353-8020(00)00064-X</mixed-citation><mixed-citation xml:lang="en">Dugan L.L., et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001;7(3):243–246. https://doi.org/10.1016/S1353-8020(00)00064-X</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Podolski I.Y., Podlubnaya Z.A., Kosenko E.A., Mugantseva E.A., Мakarova E.G. Effects of hydrated forms of C60 fullerene on amyloid β-peptide fibrillization in vitro and perfomance of the cognitive task. J. Nanosci. Nanotechnol. 2007;7(4–5):1479–1485. https://doi.org/10.1166/jnn.2007.330</mixed-citation><mixed-citation xml:lang="en">Podolski I.Y., Podlubnaya Z.A., Kosenko E.A., Mugantseva E.A., Мakarova E.G. Effects of hydrated forms of C60 fullerene on amyloid β-peptide fibrillization in vitro and perfomance of the cognitive task. J. Nanosci. Nanotechnol. 2007;7(4–5):1479–1485. https://doi.org/10.1166/jnn.2007.330</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Moussa F., Chretien P., Dubois P., Chuniaud L., Dessante M., Trivin F., Sizaret P.Y., Agafonov V., Ceolin R., Szwarc H., Greugny V., Fabre C., Rassat A. The Influence of C60 Powders on Cultured Human Leukocytes. Full. Sci. Technol. 2008;3(3):333–342. https://doi.org/10.1080/153638X9508543788</mixed-citation><mixed-citation xml:lang="en">Moussa F., Chretien P., Dubois P., Chuniaud L., Dessante M., Trivin F., Sizaret P.Y., Agafonov V., Ceolin R., Szwarc H., Greugny V., Fabre C., Rassat A. The Influence of C60 Powders on Cultured Human Leukocytes. Full. Sci. Technol. 2008;3(3):333–342. https://doi.org/10.1080/153638X9508543788</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Moussa F., Trivin F., Ceolin R., Hadchouel M., Sizaret P.Y., Greugny V., Fabre C., Rassat A., Szwarc H. Early effects of C60 administration in Swiss mice: A preliminary account for in vivo C 60 toxicity. Full. Sci. Technol. 1996;4(1):21–29. https://doi.org/10.1080/10641229608001534</mixed-citation><mixed-citation xml:lang="en">Moussa F., Trivin F., Ceolin R., Hadchouel M., Sizaret P.Y., Greugny V., Fabre C., Rassat A., Szwarc H. Early effects of C60 administration in Swiss mice: A preliminary account for in vivo C60 toxicity. Full. Sci. Technol. 1996;4(1):21–29. https://doi.org/10.1080/10641229608001534</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Baati T., Bourasset F., Gharbi N., Njim L., Abderrabba M., Kerkeni A., Szwarc H., Moussa F. The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene. Biomaterials. 2012;33(19):4936–4946 https://doi.org/10.1016/j.biomaterials.2012.03.036</mixed-citation><mixed-citation xml:lang="en">Baati T., Bourasset F., Gharbi N., Njim L., Abderrabba M., Kerkeni A., Szwarc H., Moussa F. The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene. Biomaterials. 2012;33(19):4936–4946. https://doi.org/10.1016/j.biomaterials.2012.03.036</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hendrickson O., Fedyunina N., Zherdev A., Solopova O., Sveshnikov P. Dzantiev B. Production of monoclonal antibodies against fullerene C60 and development of a fullerene enzyme immunoassay. Analyst. 2012;137(1):98–105. https://doi.org/10.1039/C1AN15745K</mixed-citation><mixed-citation xml:lang="en">Hendrickson O., Fedyunina N., Zherdev A., Solopova O., Sveshnikov P. Dzantiev B. Production of monoclonal antibodies against fullerene C60 and development of a fullerene enzyme immunoassay. Analyst. 2012;137(1):98–105. https://doi.org/10.1039/C1AN15745K</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Da Ros T., Spalluto G., Prato M. Biological Applications of Fullerene Derivatives: A Brief Overview. Croatica Chemica Acta. 2001;74(4):743–755.</mixed-citation><mixed-citation xml:lang="en">Da Ros T., Spalluto G., Prato M. Biological Applications of Fullerene Derivatives: A Brief Overview. Croatica Chemica Acta. 2001;74(4):743–755.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Belgorodsky B., Fadeev L., Ittah V., Benyamini H., Zelner S., Huppert D., Kotlyar A.B., Gozin M. Formation and characterization of stable human serum albumin-trismalonic acid [C60]fullerene complex. Bioconjug. Chem. 2005;16(5):1058–1062. https://doi.org/10.1021/bc050103c</mixed-citation><mixed-citation xml:lang="en">Belgorodsky B., Fadeev L., Ittah V., Benyamini H., Zelner S., Huppert D., Kotlyar A. B., Gozin M. Formation and characterization of stable human serum albumin-trismalonic acid [C60]fullerene complex. Bioconjug. Chem. 2005;16(5):1058–1062. https://doi.org/10.1021/bc050103c</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Думпис М.А., Николаев Д.Н., Литасова Е.В., Ильин В.В., Брусина М.А., Пиотровский П.Б. Биологическая активность фуллеренов – реалии и перспективы. Обзоры по клинической фармакологии и лекарственной терапии. 2018;16(7):4–20. https://doi.org/10.17816/RCF1614-20</mixed-citation><mixed-citation xml:lang="en">Dumpis M.A., Nikolaev D.N., Litasova E.V., Il’in V.V., Brusina M.A., Piotrovskii P.B. Biological activity of fullerenes – realities and prospects. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii (Reviews on Clinical Pharmacology and Drug Therapy). 2018;16(7):4–20 (in Russ.). https://doi.org/10.17816/RCF1614-20</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Benyamini H., Shulman-Peleg A., Wolfson H.J., Belgorodsky B., Fadeev L., Gozin M. Interaction of C60-fullerene and carboxyfullerene with proteins: docking and binding site alignment. Bioconjug. Chem. 2006;17(2):378–386. https://doi.org/10.1021/bc050299g</mixed-citation><mixed-citation xml:lang="en">Benyamini H., Shulman-Peleg A., Wolfson H.J., Belgorodsky B., Fadeev L., Gozin M. Interaction of C60-fullerene and carboxyfullerene with proteins: docking and binding site alignment. Bioconjug. Chem. 2006;17(2):378–386. https://doi.org/10.1021/bc050299g</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. [60] Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5(12):2578–2585. https://doi.org/10.1021/nl051866b</mixed-citation><mixed-citation xml:lang="en">Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. [60] Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5(12):2578–2585. https://doi.org/10.1021/nl051866b</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao L., Takada H., Gan X.H., et al. The water-soluble fullerene derivative ‘Radical Sponge®’ exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg. Med. Chem. Lett. 2006;16(6):1590–1595. https://doi.org/10.1016/j.bmcl.2005.12.011</mixed-citation><mixed-citation xml:lang="en">Xiao L., Takada H., Gan X.H., et al. The water-soluble fullerene derivative ‘Radical Sponge®’ exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg. Med. Chem. Lett. 2006;16(6):1590–1595. https://doi.org/10.1016/j.bmcl.2005.12.011</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Barzegar A., Naghizadeh E., Zakariazaden M., Azamat J. Molecular dynamics simulation study of the HIV-1 protease inhibit ion using fullerene and new fullerene derivatives of carbon nanostructures. Mini Rev. Med. Chem. 2017;17(7):633–647.</mixed-citation><mixed-citation xml:lang="en">Barzegar A., Naghizadeh E., Zakariazaden M., Azamat J. Molecular dynamics simulation study of the HIV-1 protease inhibit ion using fullerene and new fullerene derivatives of carbon nanostructures. Mini Rev. Med. Chem. 2017;17(7):633–647.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez Z.S., Castro E., Seong C.-S., Ceron M.R., Echegoyen L., Llano M. Fullerene derivatives strongly inhibit HIV-1 replication by affecting virus maturation without impairing protease activity. Antimicrob. Agents Chemother. 2016;60(10):5731–5741. https://doi.org/10.1128/AAC.00341-16</mixed-citation><mixed-citation xml:lang="en">Martinez Z.S., Castro E., Seong C.-S., Ceron M.R., Echegoyen L., Llano M. Fullerene derivatives strongly inhibit HIV-1 replication by affecting virus maturation without impairing protease activity. Antimicrob. Agents Chemother. 2016;60(10):5731–5741. https://doi.org/10.1128/AAC.00341-16</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Гунькин И.Ф., Целуйкин В.Н., Логинова Н.Ю. Синтез и изучение свойств водорастворимых производных фуллерена С60. Журн. прикладной химии. 2006;79(6):1011–1013.</mixed-citation><mixed-citation xml:lang="en">Gun’kin I.F., Tseluikin V.N., Loginova N.Yu. Synthesis and properties of water-soluble derivatives of fullerene C60. Russ. J. Appl. Chem. 2006;79(6):1001–1004. https://doi.org/10.1134/S1070427206060243 [Original Russian Text: Gun’kin I.F., Tseluikin V.N., Loginova N.Yu. Synthesis and properties of water-soluble derivatives of fullerene C60. Zhurnal Prikladnoi Khimii. 2006;79(6):1011–1013 (in Russ.).]</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Каркищенко Н.Н., Грачев С.В. (ред.). Руководство по лабораторным животным и альтернативным моделям в биомедицинских исследованиях. М.: Профиль-2С; 2010. 358 с.</mixed-citation><mixed-citation xml:lang="en">Karkishchenko N.N., Grachev S.V. (Eds.). Rukovodstvo po laboratornym zhivotnym i al’ternativnym modelyam v biomeditsinskikh issledovaniyakh (The Guide to Laboratory Animals and Alternative Models in Biomedical Research). Moscow: Profil’-2S; 2010. 358 p. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Карпищенко А.И. Медицинские лабораторные технологии. СПб.: Интермедика; 1999. 656 с.</mixed-citation><mixed-citation xml:lang="en">Karpishchenko A.I. Meditsinskie laboratornye tekhnologii (Medical Laboratory Technologies). St. Petersburg: Intermedika; 1999. 656 p. (in Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
